Morepen Laboratories Archives - Express Pharma

Morepen Laboratories receives CDSCO clearance for bioequivalence studies on Resmetirom

Morepen Laboratories expands its domestic portfolio

Morepen Laboratories to expand domestic salesforce by 1,000 as part of formulations growth plan

Morepen Laboratories secures NMPA approval for Loratadine API in China

Impact of COVID-19 on pharma formulation: Bhupendra Pratap Singh Chauhan, CQA Head, Morepen Laboratories

Morepen Labs Q3 revenue up by 29 per cent with 14 per cent jump in Profit Before Tax

RDIF and Morepen Laboratories announce test batch manufacturing of Sputnik V in India

Morepen Group gets $100 million investment from Corinth Group

Bulk drug manufacturers seek support from govt, regulatory authorities

Morepen Labs clocks double-digit growth in its sales and net profit in FY 2019-20